All In Biotech

Drug Trial Radar · NCT07110584

Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

A Phase 1/2, Multi-Center, Open-Label Clinical Study Evaluating MDX2004 In Participants With Advanced Tumors

Last checked: Nov 19, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

235

Planned (sponsor's estimate)

Start

Oct 1, 2025

Primary completion

Jun 30, 2031

Study completion Jun 30, 2031

Sponsor

Sponsor type
Industry
First posted
Aug 7, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2004 in patients with advanced tumors.

Conditions

  • Advanced Tumors

Interventions

  • MDX2004Drug

    MDX2004 intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All Study Parts: Adverse Events (AEs)Time frame: Baseline until 90 days after the participant has the last dose of MDX2004
  2. Part A only - Maximum Tolerated Dose (MTD) or Recommended Phase 2 dose (RP2D)Time frame: 28 days
  3. Part B, C, and D: Objective response rate of MDX2004Time frame: From date of enrollment until the end of treatment, up to approximately 6 months

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Liverpool Hospital

    Liverpool, New South Wales, Australia · Recruiting

  • Calvary Mater Newcastle

    Waratah, New South Wales, Australia · Recruiting

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia · Recruiting

  • Rambam Health Care Campus

    Haifa, Israel · Recruiting

  • Hadassah University Hospital-Ein Kerem

    Jerusalem, Israel · Recruiting

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.